Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carparts.Com Inc (PRTS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Carparts.Com IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Carparts.Com Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Carparts.Com Inc trades at $7.75 (market cap $63.04M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 28.6× Carparts.Com Inc's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Carparts.Com Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Carparts.Com Inc for 45 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PRTSVIR
Market Cap
$63.04M$1.80B
Volume
22,3191,782,836
Sector
Consumer CyclicalHealth
52-Week High
$10.00$11.78
52-Week Low
$3.88$5.12
Typical Hold Time
45 Days0 Days
Enterprise Value
$76.01M$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carparts.Com Inc

CarParts.com (PRTS) trades at $7.54, down 13.03% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows weak technical momentum with negative price action, while fundamentally the company faces profitability challenges with a -9.22% net margin in 2025, though revenue decline appears to be moderating. Analyst sentiment remains cautiously optimistic with 60% buy ratings, but negative cash flow and declining revenue trends present headwinds.

The outlook remains challenging with persistent losses and negative cash flow, though valuation metrics like P/S of 0.11 suggest potential undervaluation. Key risks include continued revenue contraction and inability to achieve profitability, while opportunities lie in the company's data-driven competitive positioning and potential turnaround execution. Investors should weigh the attractive valuation against fundamental deterioration.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PRTS
100% Buy0% Sell
Avg holding period · 45 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →